Conclusion There is insufficient evidence to either support or refute the practice of double checking the administration of medicines. Clinical trials are needed to establish whether double checking medicines are effective in reducing medication errors.doi:10.1136/archdischild-2011-301093...
Lack of double-checking habit considers being one of the contributing factors of medication errors. That was why this study explored the nurses' preference on single or double checking of drug administration. Six nurses were selected to be interviewed using a focus group. Nurses interviewed came fr...
Background: Double-checking medications is a widely used strategy to enhance safe medication administration in oncology, but there is little evidence to su... DLB Schwappach,K Taxis,Y Pfeiffer - 《Bmc Health Services Research》 被引量: 0发表: 2018年 Double check: diagnosis and management of ...
In those patients who take opioid and non-opioid analgesics and/or neuromodulators as usual, medication will be documented in the baseline and follow-up controls. Likewise, if a patient undergoes any infiltration or surgical intervention in the same area affected by the trial intervention, this ...
The percentage of patients with infusion reactions was balanced between garetosmab (5 of 20; 25%) and placebo (6 of 24; 25%). Some reactions required a temporary infusion interruption or antihistamine (loratadine) pre-medication (n = 2), but all infusions were completed. No patient ...
The study medication will be started within 24 hours after surgery and maintained for 12 months. The primary end point is the composite of cardiovascular death, myocardial infarction, stroke, and repeat revascularization at 12 months after CABG. The sample size is based on an expected event rate...
the physician-recorded medication history, the nurse-recorded medication history, interviews with patients, medication administration records and demographic information. The pharmacist also attempted to verify with the patient if any medication changes had been made since their clinical assessment (i.e. ...
Seven hours after the first time use of study medication, patients would be instructed to take paracetamol if their axillary temperature was still above 39°C. The use of paracetamol and any other medications was recorded in patient dairy card. Compliance was assessed by checking patient records ...
One participant was removed from the study due to initiating a medication known to alter protein metabolism during the intervention period (n = 1 MIS), and one participant was removed due to non-compliance with study visits (n = 1 MIS). Of the participants who withdrew from the study ...
None of the participants were taking anti-hypertensive medication during the trial. Sixteen participants took agents such as intestinal drugs during the test period. As the principal investigator judged that none of these were related to the test food, these participants were included in the ...